eliquis apixaban eliquis apixaban eliquis apixaban logo

This information is intended for healthcare professionals based in the UK.

If you are not a healthcare professional in the UK, please click here.

For Prescribing and Adverse Event reporting information, click here.


Risk minimisation materials

The ELIQUIS® (apixaban) Prescriber Guide and Patient Alert Card are risk minimisation materials developed for all indications, aimed at increasing awareness about the potential risk of bleeding during treatment with apixaban and providing guidance on how to manage that risk.

More information on each of these documents can be found
at www.medicines.org.uk/emc/product/2878/rmms (5 mg)

or www.medicines.org.uk/emc/product/4756/rmms (2.5 mg).


Full prescribing information is in the ELIQUIS SmPC

Download guides designed for your patients

Purple information icon ELIQUIS (apixaban) SmPC

Please click here to access the ELIQUIS SmPC.

Purple information icon ELIQUIS (apixaban) Patient Information Leaflet

Please click here to access the ELIQUIS Patient Information Leaflet.


  1. ELIQUIS® (apixaban) Summary of Product Characteristics.